Physician
Desert View Medical Center and Pediatrics, Corp
Desert View Medical Center and Pediatrics, Corp was paid $2.34M by Medicaid between Jan 2018 and Jun 2023, across 52 billing codes. Its largest line is 95165, Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials — 43% of everything it billed.
33Billing provider infoDESERT VIEW MEDICAL CENTER AND PEDIATRICS, CORP
PHOENIX, AZ 85029
PHOENIX, AZ 85029
33aNPI1790183564assigned 12/10/2014
33bProvider typeDermatology Physician
28Total paid$2.34M
24GClaims42,582
24DCodes billed52
24AFirst – last monthJan 2018 – Jun 2023
Compared with peers
Next to other Dermatology Physician providers in Arizona
Rank by total paid#5 of 44
Median peer was paid$74K
This provider vs. median31×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 22,963 | $1.31M | |
| 2019 | 2,008 | $91K | |
| 2020 | 3,406 | $191K | |
| 2021 | 9,177 | $525K | |
| 2022 | 4,331 | $198K | |
| 2023 | 697 | $31K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 95165 | Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials | 43% | 9,456 | 687 | $1.00M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 31% | 11,449 | 8,403 | $721K |
| 99354 | 11% | 2,804 | 2,171 | $249K | |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 3.8% | 1,778 | 1,439 | $89K |
| 99401 | 1.9% | 2,200 | 1,562 | $44K | |
| 93975 | <1% | 118 | 105 | $22K | |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | <1% | 250 | 245 | $22K |
| 94060 | <1% | 494 | 454 | $19K | |
| 92100 | <1% | 342 | 325 | $18K | |
| 69210 | <1% | 820 | 318 | $15K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 435 | 248 | $15K |
| 93922 | <1% | 241 | 229 | $14K |
40 more codes
| 93000 | <1% | 1,154 | $13K | |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | <1% | 69 | $13K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 575 | $10K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 339 | $9K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 132 | $8K |
| 95117 | <1% | 842 | $6K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 546 | $6K |
| 83014 | <1% | 738 | $5K | |
| 76775 | <1% | 168 | $4K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 2,079 | $4K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 284 | $3K |
| 94664 | <1% | 289 | $3K | |
| 93880 | <1% | 26 | $3K | |
| 96160 | <1% | 997 | $3K | |
| 81002 | <1% | 1,227 | $3K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 224 | $3K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 27 | $2K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 29 | $2K |
| 81025 | <1% | 212 | $1K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 72 | $1K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 13 | $1K |
| 94760 | <1% | 572 | $998.82 | |
| 95992 | <1% | 30 | $651.10 | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 14 | $623.53 |
| 90686 | <1% | 57 | $506.80 | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 31 | $493.38 |
| 92081 | <1% | 30 | $485.01 | |
| 90658 | <1% | 169 | $468.01 | |
| 76770 | <1% | 16 | $454.09 | |
| 99173 | <1% | 198 | $367.80 | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 148 | $312.45 |
| 86580 | <1% | 46 | $240.50 | |
| 80305 | <1% | 167 | $225.56 | |
| 99000 | <1% | 78 | $102.60 | |
| 82962 | <1% | 42 | $44.76 | |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 396 | $41.73 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 45 | $20.91 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 13 | $0.61 |
| 99051 | 0% | 86 | $0.00 | |
| 90633 | 0% | 15 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDALOTTO, MIRTA (OWNER/ADMINISTRATOR)
| Provider | Location | Paid |
|---|---|---|
| Nova Medical Associates, LLC | Phoenix, AZ | $3.14M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.